Precision Protocols for MTHFR Carriers: Gut, Brain, and Peptide-Supported Recovery
A clinician training for licensed practitioners ready to move beyond generic methylation advice. You will leave with variant-specific assessment frameworks, peptide mechanism literacy, lab interpretation guides, and 10+ ready-to-use protocol templates.
Participants should have a working understanding of methylation biochemistry and access to genetic testing platforms. If you are new to methylation, start with the book.
Morning: Biochemistry. Afternoon: Labs & Peptides.
Go deep on the mechanisms that generic protocols miss. C677T reduces MTHFR enzyme efficiency by 40–70% and drives NF-κB activation. A1298C depletes BH4 and produces the "wired but tired" state through a completely different pathway. Compound heterozygous patients have both — which is why single-intervention approaches fail.
Live Activity: Identify variant type and predict biochemical phenotype from anonymized 23andMe raw data.
The intestinal epithelium regenerates every 3–5 days — requiring enormous methylation-dependent resources. When methylation is impaired, tight junctions loosen, LPS enters circulation, and NF-κB fires. This is not "leaky gut wellness hype." This is documented barrier biology with methylation at its center.
Case Study: Design a gut-first protocol for Marcus — C677T homozygous, chronic bloating, elevated homocysteine (18.3), failed two elimination diets, colonoscopy normal.
Which labs to order, which to skip, and why "normal range" often misses the pattern. Core methylation panel, gut-specific labs, inflammatory markers, histamine pathway tests, and genetic confirmation. You will receive the Lab Interpretation Cheat Sheet.
Activity: Interpret three lab sets. Identify gaps in conventional workup. Design expanded panels.
BPC-157, KPV, and LL-37 — mechanisms, indications, dosing, contraindications, and sequencing. BPC-157 upregulates tight junction proteins. KPV inhibits NF-κB intracellularly. LL-37 disrupts pathogenic biofilms. Each has its place in a sequenced protocol. Research context included — these are investigational findings, not medical claims.
Live Protocol Design: Three patient cases. Design variant-specific gut protocols with peptide sequencing. Group review.
Morning: Neurochemistry & Brain Peptides. Afternoon: Protocol Design & Patient Communication.
BH4 depletion and the neurotransmitter cascade. The GABA deficit as the biochemical foundation of "wired but tired." BDNF reduction and impaired neuroplasticity. COMT and methylation-dependent catecholamine clearance. A1298C-specific presentations (anxiety, mood instability, histamine-anxiety connection) versus C677T-specific (cognitive fog, inflammatory mood changes).
Activity: Match symptom presentations to variant types. Identify which patients in your practice may be undiagnosed A1298C carriers.
Selank (GABA-A upregulation, anxiolytic without sedation, 150–450 mcg intranasal). Semax (BDNF upregulation, dopaminergic modulation, 400–900 mcg intranasal). Dihexa (synaptogenesis via HGF/c-Met, most experimental, nanogram-range). The gut-brain axis means BPC-157 is also a brain peptide — by restoring gut barrier integrity, it reduces neuroinflammatory burden traveling the vagus nerve.
Practical Exercise: Design a complete neurocognitive protocol for an A1298C heterozygous patient with anxiety, brain fog, and motivation deficits. Include sequencing and timeline.
Build complete, sequenced protocols for each variant type: C677T heterozygous (mild-moderate), C677T homozygous (severe inflammation), A1298C heterozygous (neurotransmitter/histamine), and compound heterozygous (full protocol, 6–12 months). Each protocol includes foundation support, monitoring schedule, peptide stack, sequencing rationale, and expected outcomes.
Live Case: Present a current patient case. The group designs a variant-specific protocol with sequencing rationale.
Scripts for explaining the variant without causing alarm. Why the gut comes first. Why this takes time. The difference between labs and symptoms. Why peptides are investigational. Documentation standards: variant identification, lab interpretation rationale, protocol design with sequencing, informed consent, monitoring plan, and communication logs.
Closing Q&A and certificate distribution.
Every participant receives a complete set of clinical resources — not slides, but tools you will use tomorrow.
Participants should have a working understanding of methylation biochemistry and access to genetic testing platforms (23andMe, Stratdx, NutraEval, or similar). This is not an introductory course. If you are new to methylation, start with The MTHFR Peptide Protocol book before registering.
Generic methylation advice does not account for which variant is driving the primary dysfunction. This workshop gives you the precision tools to match the protocol to the patient — not the patient to the protocol.
Register for Next Cohort →